|
Market Closed -
Nasdaq
00:00:00 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 86.13 USD | -3.28% |
|
+2.98% | +51.82% |
| 09-01 | Transcat, Inc. acquired Southeastern Biomedical Associates, Inc. for $12.8 million. | CI |
| 08-31 | Transcat Acquires Southeastern Biomedical Associates For $12.8 Million | MT |
Company Valuation: Transcat, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 557.3 | 682.3 | 983.8 | 683.1 | 665.6 | 833.5 | - | - |
| Change | - | 22.44% | 44.19% | -30.56% | -2.57% | 25.23% | - | - |
| Enterprise Value (EV) | 557.3 | 682.3 | 983.8 | 683.1 | 665.6 | 833.5 | 833.5 | 833.5 |
| Change | - | 22.44% | 44.19% | -30.56% | -2.57% | 25.23% | 0% | 0% |
| P/E | 49.4x | 63.8x | 68.4x | 46.7x | 125x | 167x | 79.9x | 55.7x |
| PBR | 6.47x | 6.78x | 4.13x | 2.37x | 2.21x | 2.67x | 2.55x | 2.4x |
| PEG | - | -9.57x | 4.2x | -12.69x | -2x | -25.38x | 1x | 1.3x |
| Capitalization / Revenue | 2.72x | 2.96x | 3.79x | 2.45x | 2.01x | 2.24x | 2.1x | 1.98x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.24x | 2.1x | 1.98x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 15.2x | 13.7x | 13.3x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 60.6x | 38.8x | 32.4x |
| EV / FCF | 0x | 0x | - | - | 0x | 41.3x | 40.3x | 29.2x |
| FCF Yield | 1.34% | 1.1% | - | - | 2.94% | 2.42% | 2.48% | 3.43% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.5 | 1.4 | 1.63 | 1.57 | 0.57 | 0.5325 | 1.115 | 1.6 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 205 | 230.6 | 259.5 | 278.4 | 331.9 | 372.9 | 397.7 | 421.1 |
| EBITDA 1 | 26.31 | 30.42 | 38.61 | 39.73 | 48.74 | 54.72 | 61.04 | 62.45 |
| EBIT 1 | 14.14 | 16.25 | 19.78 | 17.87 | 13.26 | 13.76 | 21.47 | 25.71 |
| Net income 1 | 11.38 | 10.69 | 13.65 | 14.52 | 5.376 | 5.072 | 10.76 | 15.53 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 74.09 | 89.32 | 111.43 | 73.38 | 71.32 | 89.05 | 89.05 | 89.05 |
| Nbr of stocks (in thousands) | 7,521 | 7,639 | 8,829 | 9,309 | 9,332 | 9,360 | - | - |
| Announcement Date | 23/05/22 | 22/05/23 | 21/05/24 | 19/05/25 | 26/05/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 167.23x | - | - | - | 833M | |
| 34.81x | 6.35x | 22.99x | 1% | 76.7B | |
| 37.16x | 1.24x | 13.35x | 1% | 16.52B | |
| 19.96x | 2.04x | 10.06x | 3.69% | 13.74B | |
| 25.51x | 2.85x | 12.19x | 2.93% | 11.93B | |
| 23.48x | 3.3x | 12.74x | 2.45% | 7.46B | |
| 16.21x | 0.68x | 9.53x | 1.32% | 7.15B | |
| 9.54x | 1.13x | 6.02x | 2.2% | 5.69B | |
| 19.38x | 0.41x | 9.65x | 3.85% | 5.38B | |
| 20.5x | 2.21x | 10.42x | -.--% | 5.28B | |
| Average | 37.38x | 2.25x | 11.88x | 2.05% | 15.07B | |
| Weighted average by Cap. | 30.26x | 4.13x | 17.16x | 1.6% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TRNS Stock
- Valuation Transcat, Inc.
Select your edition
All financial news and data tailored to specific country editions
